Optimize Women’s Bone Health with PureWay™ D3
- 11 September 2024
- Written by LEHVOSS Nutrition
It is known that women entering the menopause often suffer bone mineral density changes due to a decline in estrogen levels. Estrogen plays a key role in preventing bone weakening by slowing the natural breakdown of bone. Furthermore, aging is associated with a higher likelihood of vitamin D deficiency and dysregulated vitamin D function, not only this but absorption becomes less efficient with age. Supplementing with PureWay™ D3, a high-quality vitamin D optimised with Liposomax™ for better absorption and uptake, may be crucial for supporting bone health in women during this transition.
Our PureWay™ D3 is derived from lanolin and produced with true liposomal technology, a proprietary, all-natural process using no alcohols or solvents and sunflower (not soy) lecithin. This not only enhances the bioavailability of vitamin D but it also differentiates it from other forms of vitamin D on the market.
Vitamin D has several EFSA Approved Health Claims including its role in supporting normal absorption and utilisation of calcium and phosphorus, as well as the maintenance of normal bones. These EFSA Claims, combined with the advanced Liposomal technology (Liposomax™) behind our PureWay™ D3, may offer an ideal addition to your next Women's Health supplement.
To learn more about this innovative ingredient, be sure to visit our PureWay™ D3 dedicated page or contact us.
Interested in additional Liposomal ingredients? Explore our Health Platform to discover more products in the PureWay™ Liposomal range.
With almost 30 years of research and over 67 publications, 
We all know about the benefits 
Our 
As part of the 
